MedTrace Logo

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease

NCT01302015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-06-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Buerger's disease.

Conditions

  • Buerger's Disease

Interventions

BIOLOGICAL

RNL-Vascostem®

Sponsors & Collaborators

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • Sang-Hong Baek, M.D.&Ph.D. · Seoul St. Mary's Hospital

  • Eui Cheol Jeong, M.D. · SMG-SNU Boramae Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302015 on ClinicalTrials.gov